Royalty Pharma (RPRX) Shares Repurchased (2019 - 2025)
Royalty Pharma's Shares Repurchased history spans 2 years, with the latest figure at $80.5 million for Q4 2025.
- For Q4 2025, Shares Repurchased rose 53.09% year-over-year to $80.5 million; the TTM value through Dec 2025 reached $939.0 million, up 308.87%, while the annual FY2025 figure was $1.2 billion, 434.46% up from the prior year.
- Shares Repurchased for Q4 2025 was $80.5 million at Royalty Pharma, down from $708.8 million in the prior quarter.
- Across five years, Shares Repurchased topped out at $708.8 million in Q1 2025 and bottomed at $52.6 million in Q4 2024.